Thereafter, we established a prognosis signature based on four genes [CD22, CASP1, CISH, and activated leukocyte cell adhesion molecule (ALCAM)] to evaluate the prognosis for colon cancer patients (Figures 5B–D). Here, CD22 is linked to colonic neoplasm.